Form 4: Ginkgo Bioworks Director Shyam Sankar Reports Stock Transactions

Director Shyam Sankar reports acquisition and vesting of restricted stock units and stock options in Ginkgo Bioworks Holdings, Inc.

Summary

• On June 12, 2024, Shyam Sankar, a director of Ginkgo Bioworks Holdings, Inc., reported transactions involving the company's stock.
• Sankar acquired 105,263 Class A Common Stock shares through the vesting of restricted stock units (RSUs).
• Following this transaction, Sankar directly owns 2,462,137 shares of Class A Common Stock.
• On June 13, 2024, Sankar was granted 432,900 restricted stock units and 571,428 stock options.
• The exercise price of the stock options is $0.462.
• The vesting date for the RSUs and the date the stock options become exercisable is the earlier of June 13, 2025, or the day immediately prior to the next Annual Meeting of Shareholders after the grant date, contingent on continued service as a Non-Employee Director.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine stock transactions related to director compensation. There are no explicit positive or negative implications for the company's performance.

Positives

• The vesting of RSUs and grant of new RSUs and stock options to a director signals continued alignment of interests between the director and the company's shareholders.
• The director's continued service is tied to the vesting of the RSUs and exercisability of the stock options.

Future Outlook

The vesting of RSUs and exercisability of stock options are contingent on the director's continued service as a Non-Employee Director through the earlier of June 13, 2025, or the day immediately prior to the next Annual Meeting of Shareholders after the grant date.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in publicly traded companies. It provides transparency into the holdings and transactions of key personnel.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder confidence due to the alignment of interests between the director and the company.

Key Dates